Research article · 31 Dec 2022
EditorialPublished 2012
Combination Therapy for Multiple Myeloma: How Far Have We Come?
Subjects
Pharmaceutical SciencesSimilar by topic
Conference abstract · 2024
Fabrication and characterization of sterically stabilized liposomes of bortezomib in effective therapy of multiple myeloma
Conference abstract
3D-tissue engineered bone marrow as predictive tool for personalized therapy in multiple myeloma
Conference abstract
Prognosis and response to therapy can be efficiently predicted by a combination of cytogenetic aberrations, detected by interphase-FISH in newly diagnosed multiple myeloma patients
Conference abstract · 29 Oct 2018
Prognosis and response to therapy can be efficiently predicted by a combination of cytogenetic aberrations, detected by interphase-FISH in newly diagnosed multiple myeloma patients
More from this journal
The newest in Journal of Developing Drugs.
Research article · 17 Jul 2026
Effects of a Food-Derived GLP-1 Formula on Endogenous GLP-1 Secretion and Appetite Responses: A Randomized Double-Blind Crossover Study
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Apollina Goel”

